Clinical Trial Update: Drug Combinations of Atovaquone-Proguanil (AP) With ACT [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating combinations of atovaquone-proguanil with artemisinin-based combination therapy for drug-resistant Plasmodium falciparu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• Atovaquone-Proguanil (atovaquone-proguanil)

Snippet

Sponsor: Armed Forces Research Institute of Medical Sciences, Thailand | Conditions: Plasmodium Falciparum Malaria (Drug Resistant) | Phase 4 | Status: UNKNOWN